Trial site
InnoDiab Forschung Gmbh
- 22running trials
- 25closed trials
The trials here
What the 47 trials at this site are about, from their registry records.
- Conditions
- Obesity29 trials
- Type 2 diabetes28 trials
- Obstructive sleep apnoea6 trials
- Type 1 diabetes5 trials
- Chronic kidney disease4 trials
- Heart failure2 trials
- Coronary artery disease1 trial
- High blood pressure1 trial
- Peripheral artery disease1 trial
- Stroke1 trial
- Phase
- Phase 340 trials
- Phase 25 trials
- Phase 42 trials
- Status
- Completed25 trials
- Active, not recruiting12 trials
- Recruiting9 trials
- Not yet recruiting1 trial
- Lead sponsor
- Eli Lilly and Company21 trials
- Novo Nordisk A/S14 trials
- AstraZeneca3 trials
- Boehringer Ingelheim3 trials
- Amgen Inc.2 trials
- and 3 more
Running trials
Not yet recruiting
A Study of EloraTZP in Adult Participants With Obesity Without Type 2 Diabetes
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
Active, not recruiting
Weight Loss in People Living With Overweight or Obesity Following Treatment With Cagrilintide
Active, not recruiting
Recruiting
Active, not recruiting
A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Type 2 Diabetes
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Recruiting
Active, not recruiting
A Study of Retatrutide (LY3437943) Compared to Tirzepatide (LY3298176) in Adults Who Have Obesity
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Obesity7 recruiting
- Type 2 diabetes6 recruiting
- Obstructive sleep apnoea3 recruiting
- Heart failure1 recruiting
- High blood pressure1 recruiting
Closed trials
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
A Study of Orforglipron in Adult Participants With Obesity or Overweight and Type 2 Diabetes
Completed
Completed
A Research Study to See How Semaglutide Helps People With Excess Weight, Lose Weight (STEP UP)
Completed
Active, not recruiting
A Research Study to See How Well CagriSema Helps People With Excess Body Weight Lose Weight
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 14 Nov 2026